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Differences in Plasticity and Expression of Developmental Genes 
in Canine Mammary Carcinomas and Sarcomas 
Abstract 
Mammary  tumors  are  the  most  common  type  of  tumors  affecting  female  dogs. 
There is a remarkable heterogeneity among mammary tumors and the underlying 
cause  is  poorly  understood.  The  aims  of  this  thesis  were,  firstly,  to  investigate 
whether tumor cells show plasticity and thereby get insight into how heterogeneity 
arises and, secondly, to identify embryonic developmental genes expressed in the 
tumors. A comparison between sarcomas and carcinomas in these respects was of 
central importance for this investigation  
Primary tumors, an osteosarcoma, a spindle-cell tumor, and a simple carcinoma 
were cloned and resulting clones were subcutaneously injected in mice, to form 
experimental tumors. By following the expression of lineage markers in the primary 
tumors, the clones in vitro, and in the experimental tumors, it was found that the 
sarcoma clones showed distinct signs of plasticity, and that the carcinoma clones 
transformed in line with an epithelial to mesenchymal transition.  
    The  expression  of  genes  coding  for  the  developmentally  important  bone 
morphogenetic proteins was studied in the clones from the tumors described above. 
Further,  three  groups  of  tumors,  i.e.,  osteosarcomas,  fibrosarcomas  and  simple 
carcinomas  were  studied  using  gene  expression  profiling  technology.  Thereby, 
extensive  expression  of  homeobox  genes,  a  group  of  important  developmental 
genes,  was  identified.  Sarcomas  displayed  the  most  prominent  expression  of 
developmental genes, both for the number of genes expressed and the levels of 
expression for the respective genes.   
Interestingly, many homeobox genes expressed in the sarcomas have been linked 
to craniofacial development, a process dependent on neural crest contribution. In 
line with this, cell markers for neural crest derived tissues were also expressed in the 
sarcomas, including tooth, nerve and glial markers. The results show that sarcomas 
are  more  plastic  and  have  a  more  diverse  gene  expression  than  carcinomas. 
Heterogeneity  seen  in  sarcomas  of  the  mammary  gland  may  be  related  to  the 
expression of homeobox genes. 
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Introduction 
 
The mammary gland, an organ tightly associated with motherhood and the 
outermost feminine, is a complex organ with important function. Normally 
cells of the mammary gland divide, differentiate and die in connection with 
the cycling of the estrous cycle and pregnancies, but sometimes the tight 
control over a cell is lost and result in malignancy. Breast tumors are among 
the most common tumors for both women and female dogs (Ghafoor et al., 
2003; Lana et al., 2007). In this thesis the focus will be on mammary tumors 
of the dog. 
 
 
 
The mammary gland, structure and development 
Structure 
The mammary gland is like a tree. At the tips of the branches there are 
glands  ready  to  proliferate,  differentiate  and  produce  milk  in  the  case  of 
pregnancy.  Normally,  the  glands  are  in  a  resting  state  only  submitted  to 
minor proliferation/apoptosis as the organ prepares for a possible pregnancy 
with every estrous cycle. From the glands run ducts that collate with other 
ducts with a final purpose to collect and bring the milk to the nipple (Figure 
1a).  
 
The  epithelium  lining  the  mammary  ducts  and  glands  is  a  compound 
epithelium  consisting  of  ductal  or  luminal  epithelium  enclosed  by  a 
myoepithelial meshwork. The myoepithelial layer (Figure 1b) can contract 
in response to oxytocin stimulation and has an important function in the 
release of milk (Gudjonsson et al., 2005)   10 
 
 
 
 
 
 
 
 
 
 
Fig. 1. The duct system of the canine mammary gland A. Section of the mammary gland 
tissue visualizing the compound epithelia illustrated by dark myoepithelial cells lining the 
luminal epithelial layer B. 
 
Development 
The  processes  required  to  induce  mammary  bud  development  (epithelial 
migration, change in cell adhesion, growth, death and differentiation) are 
also  similar  to  the  processes  involved  in  mammary  tumor  development 
(Howard  and  Ashworth,  2006).  The  mammary  gland  is  the  result  of  a 
proliferation and ingrowth of the embryo ectoderm during development. 
Pluripotent epidermal cells are directed in specific lines of differentiation and 
a  specialized  structure  forms  (Howard  and  Ashworth,  2006).  There  are 
several structures in embryo development such as hair follicles and teeth that 
form in the same way as the mammary gland, from a skin appendage, and 
there are common features in the development (Mikkola and Millar, 2006). 
A number of common genes are expressed in hair follicle, and teeth as well 
as in mammary gland, and deletion of some genes affects development of all 
the epidermal appendages (Hennighausen and Robinson, 2001). Among the 
genes  that  have  been  identified  as  crucial  in  early  mammary  gland 
development  are  the  families  of  homeobox  and  bone  morphogenetic 
protein (BMP) genes, two families of important developmental genes that 
will be in focus in this thesis (Cho et al., 2006; Phippard et al., 1996). In 
addition fibroblast growth factor and Wnt signaling has been identified as 
very important for mammary gland development (Pispa and Thesleff, 2003). 
The  embryonic  mammary  gland  development  is  highly  dependent  on 
interactions  between  the  epithelium  and  the  underlying  mesenchyme.  
Signals  from  the  surrounding  extracellular  matrix  promote  branching 
morphogenesis  into  the  mammary  fat  pad  during  normal  mammary 
development (Fata et al., 2004; Robinson, 2007)(Figure 2). Experimental   11 
models  have  contributed  largely  to  the  knowledge  of  mammary 
development.  Murine  mammary  epithelial  buds  can  be  isolated  and 
transplanted into fat pads cleared of epithelial elements. This model enables 
studies of gene function in the mammary gland with genes that otherwise 
for example would have been embryonically lethal (Howard and Ashworth, 
2006; Jackson-Fisher et al., 2004; Robinson, 2004)  
 
 
 
 
 
 
 
 
 
 
Fig. 2. Embryonic mammary gland development. The development is, in contrast to the 
adult  developmental  stages,  hormone  independent.  To  date,  several  regulators  have  been 
identified:  Milk  line  formation  is  dependent  on;  fibroblast  growth  factor  10  (FGF10), 
fibroblast  growth  factor  receptor  2  (FGFR2),  WNT10b/6,  neuregulin  3,  Erythroblastic 
leukaemia  viral  oncogene  homologue  2/4  (ERBB2/4),  TBX2/3  and  Gli-Kuppel  family 
member 3 (GLI3). Placecode; WNTs, FGFs, BMP4, TBX2/3 and Lef-1. Mammary bud 
epithelium;  Parathyroid  hormone-like  hormone  (PTHLH),  Insulin-like  growth  factor  1 
(IGF1), BMP4, Lef-1, MSX1/2, TBX3 and GLI3. Mammary bud mesenchyme; Parathyroid 
hormone receptor 1 (PTHR1), BMP4, BMPR1A and MSX2. (Robinson, 2007). There is 
less  information  on  later  developmental  stages,  which  might  be  because  the  primary 
mammary sprout is hard to distinguish from hair follicles, when they have formed. Another 
reason  might  be  that  factors  have  different  roles  at  different  stages  of  development. 
Impairment at an earlier developmental stage will obscure a role later in development.  
 
The prenatal development of the mammary gland is hormone independent 
and  the  gland  is  in  a  resting  state  until  hormone  levels  rise  at  puberty 
(Robinson,  2007).  It  is  a  special  organ  in  the  sense  that  it  is  not  fully 
developed before birth and that it is dependent on distant hormonal control 
for its terminal development.  
Cell markers 
In order to study the mammary gland, both during normal function as well 
as in disease, it is important to be able to identify the different cell types 
comprising  the  gland  and  surrounding  tissues,  by  using  cell  type-specific 
markers. There are a number of such markers that have been used over the 
years and new markers for especially mammary progenitors and stem cells   12 
are regularly identified (Behbod et al., 2006; Dontu et al., 2003; LaBarge et 
al.,  2007;  Shackleton  et  al.,  2006;  Woodward  et  al.,  2005).  The  major 
components of the mammary gland, for example the luminal epithelium and 
the myoepithelial cells, can be identified by the expressed filaments. The 
majority of the markers used in Paper I fall into this category. Examples of 
epithelial markers are cytokeratins of which there are more than 20 different 
types  with  different  expression  pattern  in  myo-  and  luminal  epithelium 
(Asch and Asch, 1985; Upasani et al., 2004). Other examples of filament 
markers  are  vimentin  (expressed  in  mesenchymal  cells),  neurofilament, 
smooth muscle actin and skeletal myosin. The expression of filaments can be 
used  when  characterizing  tumors  and  tumor  cells  with 
immunohistochemistry (Destexhe et al., 1993; Hellmen and Lindgren, 1989; 
Hellmen et al., 2000). 
 
 
 
Canine mammary tumors 
Incidence and breeds 
Mammary tumors are the most common form of tumor affecting female 
dogs (Bonnett et al., 2005; Lana et al., 2007). A fact that is becoming more 
and  more  clear  is  that  the  frequency  of  mammary  tumors  varies  among 
different breeds of dogs. To date, several large studies have addressed the 
incidence of mammary tumors, and breeds found to have high risk include 
English springer spaniel, Doberman, Cocker spaniel and Boxer (Dobson et 
al., 2002; Egenvall et al., 2005; Moe, 2001). The geographical location of 
the studied dog populations seems to affect the incidence rates of breeds. In 
this thesis, the studied tumors come from different breeds. The biology of 
the mammary tumors, i.e., the type and malignancy, are so far thought to be 
the same among breeds, although there is a study claiming that small sized 
breeds are less prone to acquire malignant tumors (Itoh et al., 2005).  
 
A  method  that  substantially  reduces  the  risk  of  mammary  tumors  is 
ovariohysterectomy at an early age. The procedure of neutering only has 
effect if it is done early in the dog’s life; before the first estrus gives the best 
protection  with  a  risk  of  0.5%  of  developing  mammary  tumors.  If  the 
procedure is done before the second estrous the risk is 8%. After the second 
estrus and any estrus thereafter the risk of developing mammary tumors is 
26% (Schneider et al., 1969). The findings thus suggest that development of 
mammary gland tumors is dependent on the endocrine environment, the   13 
first  few  estrus  cycles  seem  critical,  and  that  it  can  be  manipulated  by 
neutering.  
 
Biology of tumors 
Tumors  of  the  mammary  gland  are  very  heterogeneous  in  terms  of 
morphology  and  biological  behavior.  The  majority  of  the  tumors  have 
epithelial  morphology,  i.e.  carcinomas  and  a  minority,  4-8%,  are  of 
mesenchymal  morphology,  i.e.  sarcomas  (Bostock,  1986;  Hellmen  et  al., 
1993). There are several types of both carcinomas and sarcomas. Carcinomas 
are, for example, further divided into simple and complex carcinomas where 
simple  carcinomas  are  of  tubulopapillary,  solid  or  anaplastic  type  and 
complex carcinomas have both luminal and myoepithelial cells as part of the 
tumor. Examples of sarcomas are fibrosarcomas and osteosarcomas (Misdorp 
et al., 1999). The origin of mammary tumors has for long time been under 
debate,  especially  the  origin  of  cartilage  and  bone  is  questioned.  Several 
alternative  originating  cells  have  been  suggested,  including  myoepithelial 
cells  (Espinosa  de  los  Monteros  et  al.,  2005)  and  pluripotent  stem  cells 
(Gartner et al., 1999; Hellmen et al., 2000), with these alternatives also being 
considered in human breast cancer research (Leibl et al., 2005; Leibl and 
Moinfar, 2006; Polyak, 2007; Reis-Filho et al., 2006; Sorlie et al., 2001). 
 
Comparative aspects  
The  question  is  whether  research  on  canine  mammary  tumors  can 
contribute to the advancement of knowledge and ultimately the treatment 
of  breast  tumors  affecting  women.  Research  on  spontaneous  canine 
mammary  tumors  has  been  performed  for  many  decades  but  still  canine 
tumors are not very well established as a model for human malignancies. A 
major step forward for canine research was the release of the canine genome 
in 2005 (Lindblad-Toh et al., 2005) which opened the door for advanced 
canine  medical  research.  Importantly,  the  biology  of  canine  mammary 
tumors and human breast tumors are very similar in many aspects. Dogs are 
large and relatively outbred compared to laboratory animals and the genetic 
differences among breeds offer a cross-sectional value higher than that in 
studies  of  inbred  rodent  models  (Paoloni  and  Khanna,  2008).  The 
background genetic diversity in dog breeds is similar to that seen in human 
populations based on single nucleotide polymorphism frequency (Lindblad-
Toh et al., 2005). Genes involved in tumor development (MET, IGFIR, 
KIT, mTOR and P53) have been compared between species and the canine   14 
genome showed greater similarities to the human DNA sequence compared 
to the mouse (Chu et al., 1998; Hoffman and Birney, 2007; Paoloni and 
Khanna, 2008), an indication that the canine model can be a resource in 
tumor  research  in  general.  Another  study  suggests  a  comparative  aspect 
between  mixed-type  tumors  from  human  salivary  and  canine  mammary 
glands (Genelhu et al., 2007). There are several examples of similar biology 
and histology of mammary tumors between humans and dogs. For example, 
mammary  sarcomas  show  the  same  metastasizing  patterns  in  both  species 
(Fong et al., 1993; Gullett et al., 2007; Silver and Tavassoli, 1998). Another 
example is a study that evaluated new classifications of human mammary 
tumors based on gene expression profiling data on canine specimens. The 
classification was applicable on canine tumors and could predict outcome 
(Gama et al., 2008). 
 
 
 
Mechanisms behind tumor heterogeneity 
Tumor stem cells 
One of the most important and useful properties of stem cells is that they 
can  self-renew  and  there  are  striking  similarities  between  stem  cells  and 
tumor cells regarding this property. The idea that tumors in fact may be the 
result of a transformed normal stem cell is still under investigation (Reya et 
al.,  2001).  Tumor  stem  cells  were  first  identified  in  the  hematopoietic 
system (Bonnet and Dick, 1997) but it was not until recently that tumor 
stem cells in solid tumors were identified, including breast tumors (Al-Hajj 
et  al.,  2003).  There  is  an  increasing  amount  of  evidence  suggesting  that 
tumors contain a fraction of cells that have stem cell properties (Hermann et 
al.,  2007;  O'Brien  et  al.,  2007;  Singh  et  al.,  2004).  There  are  also 
advancements  in  the  techniques  of  isolating  or  enriching  cell  cultures  of 
tumor stem cells. For example the combination of suspension culture with 
chemotherapeutics enriches tumor stem cells (Li et al., 2008). Identification 
and isolation of the tumor stem cells is the key to the development of novel 
treatments and therapeutics. 
 
Whether tumor stem cells can be generated from normal stem cells remains 
to be shown. Another possible way for a tumor stem cell to form is by 
reprogramming a differentiated cell. This way of transformation has been 
demonstrated recently and is a breakthrough in stem cell research. It has 
been shown that adult fibroblasts, by mutations of very few genes, can be   15 
reprogrammed into pluripotent embryonic-like stem cells (Takahashi et al., 
2007; Yu et al., 2007). It is thereby shown that certain genes and signal 
pathways have a very strong impact on stem cell properties. In combination 
with oncogenes it is possible to keep tumor stem cells in an undifferentiated 
state (Ben-Porath et al., 2008). 
 
Clonal evolution  
Another  force  that  is  working  in  tumors  is  clonal  evolution  or  clonal 
heterogeneity. In a population of tumor cells, unique mutations will occur 
in single cells. The cell with the unique mutation will give rise to a cell 
clone and an accumulation of different mutations will cause the tumor cells 
to gain or lose properties that make them different from each other. The 
force  of  evolution  will  make  clones  with  beneficial  mutations  the 
dominating cells in the tumor. Clonal evolution can explain heterogeneity 
within a tumor as well as the finding that cancer stem cells can differentiate 
and  cause  heterogeneity.  There  is  substantial  evidence  for  both  clonal 
evolution  and  the  cancer  stem  cell  model  and,  importantly,  there  are 
indications that the models are not necessarily mutually exclusive (Campbell 
and Polyak, 2007). 
 
 
 
Developmental genes and events in tumors 
Epithelial to mesenchymal transition 
The  cells  in  an  epithelial  tumor,  a  carcinoma,  need  to  escape  the  tight 
attachment to neighboring cells to be able to move from the primary tumor 
and establish distant metastases. The mechanism behind this phenomenon is 
called  epithelial  to  mesenchymal  transition  (EMT) (Thiery,  2003;  Thiery 
and Sleeman, 2006). In early embryonic development, EMT is essential and 
the active process behind the formation of the mesoderm (Trelstad et al., 
1966) followed by the development into multiple tissue types (Nakaya and 
Sheng, 2008). It has also a role in wound healing (Savagner et al., 2005). 
Through developmental and tumor studies, many of the molecular actors 
behind EMT have been identified (Cano et al., 2000; Comijn et al., 2001; 
Hartwell et al., 2006; Yang et al., 2004). The EMT concept is established 
and well studied. Recently a new direction of the concept opened up when 
it was suggested that EMT generates cells with properties of self-renewing 
stem cells (Mani et al., 2008).    16 
 
Homeobox genes, tumors and metastasis 
Homeobox transcription factors are among the most important families of 
transcription factors in embryo development. Homeobox domains were first 
discovered in homeotic genes of the antennapedia and bithorax complex in 
Drosophila (McGinnis et al., 1984; Scott and Weiner, 1984) with the role of 
determining the morphologic character of the body segments. A mutation 
of these genes can cause bizarre malformations such as extra sets of wings or 
legs  instead  of  antennae.  The  DNA  sequence  characteristic  for  the 
homeobox encodes a recognizable although very variable protein domain, 
the homeodomain (Gehring et al., 1990; Kissinger et al., 1990). The vast 
majority of the homeodomains are 60 amino acids long. In vertebrates they 
have  important  roles  in  embryo  patterning  (Cho  et  al.,  1991),  cell 
differentiation and migration (Niehrs et al., 1993) and have been implicated 
in disease and congenital abnormalities (Dobreva et al., 2006). The reported 
number of homeobox genes in the genome varies quite significantly in the 
literature. Recently a thorough investigation was performed that identified 
235  probable  functional  homeobox  genes  and  65  probable  pseudogenes 
(Holland et al., 2007). Homeobox genes are well organized in the genome 
where  they  are  expressed  in  a  very  controlled  spatiotemporal  manner  in 
development  (Iimura  and  Pourquie,  2007)  and  they  are  important  for 
mammary development (Chen and Sukumar, 2003). There are significantly 
fewer studies of developmental genes in mammary development compared 
to  other  organ  systems.  The  reason  is  simply  that  much  of  fundamental 
developmental research is performed in Drosophila, Xenopus Zebrafish and 
avian  (chicken)  model  systems.  Those  model  systems  are  in  many  ways 
easier to work with than mice but they lack mammary glands. In mammary 
development the homeobox genes MSX1/2 have been shown to have a 
role in the development of the mammary bud epithelium (Robinson, 2007) 
and MSX2 in branching morphogenesis (Satoh et al., 2007).  
 
Homeobox  genes  are  not  only  expressed  in  the  embryo,  they  are  also 
important  for  functional  differentiation  in  the  adult  where  they,  for 
example, have been linked to milk production (Chen and Capecchi, 1999). 
Despite  the  known  function  of  homeobox  genes,  the  regulatory 
mechanisms  that  drive  homeobox  expression  are  poorly  understood. 
However, in recent studies several hormones and their cognate receptors 
have been implicated in homeobox gene regulation and thereby embryonic 
development as well as in functional differentiation in the adult. Further, 
estradiol, progesterone, testosterone, retinoic acid, and vitamin D have been   17 
shown to be involved in homeobox gene regulation (Daftary and Taylor, 
2006). 
 
There  is  an  increasing  interest  in  homeobox  genes  and  their  role  in 
tumorigenesis and metastasis. Homeobox genes have been shown to have a 
role in EMT (Comijn et al., 2001; Hartwell et al., 2006), detachment and 
tumor  metastasis.  Homeobox  genes  are  master  regulators  and  have  been 
shown to regulate many other genes. One example is SatB1 which has been 
shown to control the expression of many other genes by controlling DNA 
methylation (Yasui et al., 2002) and the injection of Goosecoid into the 
ventral side of a xenopus embryo generates an additional body axis including 
head structures and notocord structures (Cho et al., 1991). Both SatB1 and 
Goosecoid have roles in tumor metastasis (Han et al., 2008; Hartwell et al., 
2006) by controlling genes for example associated with cell adhesion. 
 
BMPs, tumors and metastasis 
BMPs  are  members  of  the  transforming  growth  factor  beta  (TGF-β) 
superfamily. As the name implies they are involved in the process of bone 
differentiation as discovered two decades ago (Wozney, 1989), but they are 
also  involved  in  other  processes  during  development  and  they  are  also 
important in tumor biology. The BMP signal is transduced to the nucleus 
via phosphorylation of the signal transducer proteins Smad 1, 5 and 8 which 
together with Smad 4 immediately relocalize to the nucleus and the target 
genes  (Shi  and  Massague,  2003).  To  date,  about  15  BMPs  have  been 
identified and characterized. Experiments have shown that the knockdown 
of many BMP genes have embryo lethal effect and in the case of BMP 2 and 
4 the effects occur very early in the development (Chang et al., 2002). In 
development, BMPs are required for the dorsoventral patterning within the 
neural  tube,  introduction  of  mesoderm  during  gastrulation  and 
hematopoiesis (Attisano and Wrana, 2002). BMPs have also been shown to 
regulate  the  lineage  decision  of  differentiation  in  neural  crest  stem  cells 
(Shah et al., 1996)and are known to work together with homeobox genes in 
mammary development (Phippard et al., 1996).  
 
In tumor biology there have not been so many studies on BMPs compared 
to  the  massive  focus  on  the  TGF-βs  in  the  same  superfamily.  Recently 
however there is a growing number of studies implying a role for BMPs in 
tumors, mainly in the metastasizing process (Alarmo et al., 2007; Helms et 
al., 2005; Montesano, 2007). In canine mammary tumors, BMP-6 and BMP   18 
receptors have been identified in myoepithelial cells (Akiyoshi et al., 2004; 
Tateyama et al., 2001) and BMP-2/4 in a mammary osteosarcoma cell line 
(Kawabata et al., 2006). 
 
Retinoic acid 
For years vitamin A (retinol) and its corresponding metabolite retinoic acid 
have been known to be essential for embryo development. On the other 
hand, excess of these substances will result in severe congenital abnormalities 
that  can  involve  the  face,  eye,  hindbrain,  limbs  and  urogenital  system. 
Further,  too  little  or  too  much  retinoic  acid  can  also  result  in  serious 
disturbances  in  the  development  of  the  hindbrain  and  pharyngeal  neural 
crest  (Carlson,  2004).  In  experimental  setups,  retinoic  acid  can  cause 
homeotic  changes,  i.e.  an  extra  pair  of  limbs  in  amphibians  (Mohanty-
Hejmadi et al., 1992). Homeobox genes are known to be targets of retinoic 
acid (Daftary and Taylor, 2006) and homeobox genes are likely to be the 
cause of the teratogen effect of retinoic acid (Williams et al., 2004).  
 
Neural crest and craniofacial development  
Homeobox  genes,  BMPs  and  retinoic  acid  are  all  associated  with  neural 
crest and craniofacial development (Daftary and Taylor, 2006; Golding et al., 
2000; Liem et al., 1995; Trainor et al., 2003; Tribulo et al., 2003; Williams et 
al., 2004). Neural crest originates from cells that migrate from the lateral 
margins of the neural plate. The migration is induced by signals from the 
non-neural ectoderm and a gradient of BMP 4 and 7 (Liem et al., 1995) as 
well as Wnt (Steventon et al., 2009) is important for the induction. The 
very first step of neural crest formation is for neural crest cells to lose the 
epithelial morphology, the attachment to the neighbors, and be submitted to 
EMT.  This  step  is  of  high  interest  in  tumor  and  metastasis  research  and 
neural crest formation can offer a natural model for EMT and metastasis 
(Acloque et al., 2008). Detached neural crest cells have the ability to move 
through the basal lamina of the neuroepithelium and sequentially undergo a 
remarkable series of migrations throughout the developing embryo (Trainor 
et al., 2003).  
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Gene expression profiling of breast cancer 
 
The relatively new technique of global gene expression analysis of primary 
tumors and cell lines has provided a powerful tool to find new subclasses of 
tumors  relevant  for  treatment  and  prognosis  but  also  to  gain  more 
knowledge of the tumorigenesis. Much effort has been put into finding a 
“minimal”  set  of  genes  to  identify  subclasses  of  tumors  and  there  are 
examples  of  identified  gene  sets  that  have  been  successful  in  predicting 
outcome of disease (Buyse et al., 2006; Fan et al., 2006; Paik et al., 2004; 
van't Veer et al., 2002).  Out of the very few expression array studies that 
have been performed on canine tumors, there is one example of expression 
analysis  in  canine  gliomas  (Thomson  et  al.,  2005)  and  canine  mammary 
tumor cell lines have also been subjected to expression array analysis (Rao et 
al., 2008).     20   21 
Aim of study 
The overall aim with this thesis was to gain information about the plasticity 
of  mammary  tumor  cells  and  expression  of  a  number  of  genes  active  in 
normal embryo development. It was also to compare plasticity and gene 
expression between carcinomas and sarcomas. 
 
The specific aims were: 
   
• To investigate the plasticity of cloned cell lines from three primary tumors, 
an osteosarcoma, a spindle-cell tumor and a simple scirrhous carcinoma, by 
comparing protein expression patterns in the primary tumors, the cloned 
cell lines and in the experimental tumors formed by the cell clones. 
       
↟ To investigate the mRNA expression profile of BMPs in cloned cell lines 
and make an attempt to correlate the profile with the phenotype of the 
experimental tumors formed by the clones. 
 
↟ To compare the global mRNA expression patterns in three groups of 
tumors (osteosarcomas, fibrosarcomas and simple carcinomas) as well as to 
non-malignant  mammary  tissue  (NMT).  Moreover,  and  if  possible,  to 
identify  developmental  master  genes  i.e.  genes  that  regulate  many  other 
genes. 
 
 
 
 
   22   23 
Comments on materials and methods 
 
Primary Tumors 
 
The primary mammary tumors in Paper I and II were a simple scirrhous 
carcinoma, an osteosarcoma and a spindle-cell tumor. The carcinoma and 
the osteosarcoma came from the same dog.  
 
When the tumors for the expression array were selected, the initial idea was 
to choose both mammary carcinomas and sarcomas. The carcinoma group 
chosen  was  of  the  simple  carcinoma  subtype,  i.e.  monophasic  tumors 
comprising one type of neoplastic cells.  The sarcoma groups chosen for the 
study were fibrosarcomas and osteosarcomas. All tumors were malignant.  
 
 
Cell culture, cell cloning 
 
The cloning was performed carefully to assure the origin of a clone from 
one cell. The experimental design in Paper I and II was dependent on one 
cell  as  the  origin  of  one  clone  and  failure  would  have  hampered  the 
interpretation  of  the  results.  The  cells  were  plated  sparsely  by  seeding 
approximately  30  cells  per  10-cm  cell  culture  dish.  The  following  day, 
single cells with large distance to neighbors were marked out with a pen and 
later chosen.  
   24 
To decrease the influence of in vitro clonal evolution the experiments were 
performed with as low passages of the cloned cells as possible in the two 
studies. For the establishment of the experimental tumors in Paper I and II 
passages 4-9 were used, with the majority around 5. That means that the 
cells were in culture very short time. It is also worth mentioning that the 
primary cell lines were cloned at a low passage (around 20). 
 
 
Stimulation of cell lines with BMP-2 
 
Cells were stimulated for 1 hour with BMP. It has been shown for the 
TGF-β  pathway,  which  has  Smad-4  as  a  common  signal  transmitter 
together with the BMP pathway, that it only takes minutes of stimulation to 
get a relocation of signal transmitters to the nucleus (Pinidiyaarachchi et al., 
2008).  Hence  the  stimulation  time  was  adequate  and  we  also  observed 
activation. As a control of the activation the anaplastic thyroid carcinoma 
cell line HTh 74 was used because of its known ability to respond to BMP 
stimulation (Heldin et al., 1991). 
 
 
Immunohistochemical analysis 
 
The immunohistochemical characterization of the cell clones used in Paper I 
and II was performed on frozen cells and control specimens. The fixation 
was  performed  with  acetone,  which  is  adequate  for  many  antibodies  on 
frozen tissues. 
 
In  the  following  immunohistochemical  analyses  on  formalin  fixated  and 
paraffin imbedded tissues in Paper I-III, an efficient antigen retrieval was 
required to expose the epitopes for the antibodies. A heat-mediated antigen 
retrieval in a boiling chamber is very efficient and the buffer and the boiling 
time can be optimized for every antibody. When the conditions for the 
antibodies in this thesis were optimized different buffers were tested and 
boiling times were keep constant to reduce the variable parameters.  
 
The  immunohistochemical  analyses  of  bone  sections  were  extremely 
difficult technically. The first difficulty lay in the fact that bone is very hard 
to section. It needs to be decalcified which may influence the morphology 
and epitopes if this is too harshly performed. After decalcification, perfect   25 
sections  are  nevertheless  difficult  to  obtain  due  to  the  hardness  of  the 
material. The largest problem is however that bone and nuclei in the bone 
area detach from the slide in the heat-mediated antigen retrieval process. 
Specially  coated  slides  (Super  Frost  Gold)  were  used  to  overcome  this 
problem, but still some detachment occurred.  
 
The antigen retrieval method is highly dependent on the antibody it is used 
for. For collagen type I and II antibodies (Paper I), it was adequate to treat 
the  deparaffinized  sections  with  pepsin  in  order  to  reveal  the  epitopes. 
Those  slides  were  therefore  never  subjected  to  heat  mediated  antigen 
retrieval, hence the excellent morphology of those immunohistochemical 
analyses.  
 
For immunohistochemical analysis, one of the most important steps is the 
selection  of  the  antibody.  Commercial  antibodies  raised  against  canine 
proteins are extremely rare. However, it is becoming more common that 
dog  is  included  among  the  species  antibodies  are  tested  against  by  the 
companies. The release of the canine genome also makes it possible to do an 
alignment  between  the  peptide  the  antibody  is  raised  against,  usually  of 
human or murine origin, and the corresponding canine sequence. That is no 
guarantee of good performance but it is a hint of how the antibody will 
perform on canine tissues.  
 
With all the antibodies, both positive and negative controls were used. For 
neurofilaments,  the  stroma  around  the  tumor  provided  peripheral  nerves 
that could be used as internal positive controls. 
 
The antibodies generated within the Swedish Human Protein Atlas Project 
(HPA)  (Uhlen  et  al.,  2005)  (Paper  III)  were  raised,  in  rabbits,  against 
peptides  of  human  origin.  The  antibodies  were  generated  using  an 
antibody-based proteomics approach (Uhlen and Ponten, 2005). Antibodies 
were affinity purified on columns coated with the antigens they were raised 
against. The strength of the HPA antibodies is the careful validation with 
Western blot and IHC on tissue microarrays (TMA) with a high coverage of 
tissue  types  and  tumors.  In  that  way  protein  expression  patterns  and 
antibody performance can be analyzed in detail.  
 
TMAs are an efficient way of analyzing many tissues at the same time by 
IHC. The method can significantly increase the throughput of an otherwise 
labor-intense and time-consuming method as IHC (Kononen et al., 1998).   26 
In the second paper in this thesis, a TMA was constructed to overcome the 
problem  of  performing  IHC  on  bone  tissue.  The  osteosarcomas  were 
possible  to  section  although  the  resulting  sections  could  be  more  or  less 
intact. The large obstacle to overcome was that the bone tissues present in 
the osteosarcomas frequently fell off the slide in the antigen retrieval process. 
A TMA was constructed from the experimentally osteosarcomas (Paper II) 
and the punches were taken in cell-dense areas of the tumors without bone 
tissue.  This  approach  was  successful  and  the  experimental  osteosarcoma 
TMA could thus be used for IHC analyses. 
 
 
DNA index 
 
The DNA content (DNA index) of the clones  (Paper I)  was studied with 
flow cytometry. Despite being a crude method, all the clones had, before 
the  injection  in  nude  mice,  single  peaks  with  measurable  differences  in 
DNA content between the clones, i.e. if two clones had been mixed or 
there had been a clonal evolution (with the same magnitude of the loss or 
gain of DNA as between the clones) there would have been two (or more) 
G1 peaks. 
 
 
Tumorigenicity in nude mice 
 
The  generation  of  experimental  mammary  tumors  was  performed  with 
female Balb/c nu/nu mice. The influence of hormones to the genesis of 
mammary  tumors  is  a  factor  to  take  into  account  when  designing  the 
experiments. Therefore, only female mice were used to reduce the influence 
of unknown variables in our experiments. 
 
 
Ribonuclease Protection Assay (RPA) 
 
This  method  is  quantitative  and  sensitive.  In  brief  total  RNA  from  the 
different clones were hybridized to probes of different length designed to 
detect  mRNAs  of  BMP-1,  -2,  -3,  -3B,  -4,  -5,  -6,  -7,  -8A  and  -8B, 
including L32 and GAPDH as internal controls. The 
32P-labeled antisense 
RNA probes in this method vary considerably in length for the different   27 
BMP genes, from 125 to 381 nucleotides. After hybridization, ribonuclease 
was added to degrade unprotected, unhybridized single stranded RNA. The 
differences of the probes in length are necessary for the separation on an 
acrylamid gel and identification of the different bands. The probe set used 
(Paper  II)  was  designed  for  mouse  and  therefore  the  human  thyroid 
carcinoma cell line Kat-4 was used as an extra positive control in addition to 
the positive mouse control provided with the RPA kit. The localization of 
the canine BMP bands on the gel was directly comparable with those of the 
mouse control and the BMPs expressed in the human cell line Kat-4. The 
interpretation  of  the  controls  was  that  the  probes  gave  a  reliable 
identification of expressed canine BMP genes. The relatively long probes 
probably  contributed  to  the  reliability.  Mismatched  probes  would  most 
probably  have  been  digested  by  the  RNase  and  interpreted  as  (false) 
negative expression, a more likely scenario in inter-species hybridizations 
and RPA than a false positive match. 
 
 
RNA preparation and quality validation for expression analysis 
 
The  quality  of  the  RNA  for  an  expression  array  analysis  is  essential. 
Therefore, considerable effort was put into assuring as good quality of the 
RNA  from  the  primary  tumors  as  possible.  The  vast  majority  of  tested 
tumors  did  not  qualify.  The  RNA  was  first  prepared  by  pulverizing  the 
tumor specimen under liquid nitrogen followed by addition of Trizol. The 
quality was first measured with an Agilent 2100 Bioanalyzer and a second 
time  after  the  RNA  purification  on  Qiagen  mini  columns.  The 
concentrations were measured on a NanoDrop ND-1000 spectophotometer 
after purification. 
 
 
The Affymetrix method 
 
Affymetrix GeneChip
 expression arrays (Canine Genome 2.0 Array) were 
used, a high-resolution array produced with a photolithography technique. 
The technique of production differs from other expression array platforms 
and  is  adapted  from  the  semiconductor  industry.  One  by  one  the 
nucleotides are added to the chip and 25-mer oligonucleotide probes are 
built. About 15 unique probes are designed for every gene and every probe   28 
has millions of copies (Dalma-Weiszhausz et al., 2006). One sample is used 
for  one  array  hybridization  and  result  in  a  quantitative  figure  on  gene 
expression since the number of probes is controlled.    29 
Result and discussion  
In  this  thesis,  Paper  I  and  II  are  related  and  investigate  three  primary 
mammary tumors (a spindle-cell tumor, an osteosarcoma and a carcinoma), 
the cell clones generated from the primary tumors (referred to as the in vitro 
step) and the experimental tumors generated from the clones, in vivo step 
(see  Fig.  3).  Paper  I  mainly  focuses  on  the  plasticity  by  following  the 
expression of cellular markers in the primary tumors, the cloned cell lines 
and eventually in the experimental tumors generated from the clones. Paper 
II focuses on the expression of BMP genes, BMP-6 protein expression and 
the activation of the BMP signaling pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Experimental outline for Paper I and II 
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The experimental design is unusual; it generates considerable information 
from  a  small  number  of  primary  tumors.  The  common  way  of  studying 
clonality in solid tumors is, for example, to use polymerase chain reaction 
(PCR) or comparative genomic hybridization (CGH) to study differences in 
mutations  in  different  parts  of  the  tumor (Jones  et  al.,  2000;  Lien  et  al., 
2004). In such an approach, DNA is extracted from fixed and thereby dead 
tissue. The advantage of the design used here is that living cell clones were 
studied. 
 
 
Plasticity or clonal evolution? (Paper I) 
 
A  very  interesting  observation  was  that  three  different  clones  from  the 
primary osteosarcoma did not express any of the cellular markers tested for 
in  vitro,  but  the  same  clones  formed  highly  differentiated  experimental 
osteosarcomas.  The  clones  from  the  spindle-cell  tumor  also  formed 
experimental tumors with foci of highly differentiated bone. The primary 
tumor did not have any bone formation. By following the expression of 
filaments in primary tumors, clones in vitro and in the experimental tumors, 
the  conclusions  were  that  spindle-cell  and  osteosarcoma  clones  showed 
plasticity, i.e. the clones had the ability to turn off and on genetic programs. 
For  example,  vimentin  expression  may  have  been  turned  off  in  three 
different osteosarcoma clones (clone 1, 2 and 7) when they were cloned and 
cultured. Nearly all of the tumor cells in the primary osteosarcoma were 
vimentin positive. In cell culture, all cells in the three clones were negative 
to all markers tested, an indication of very immature cells (Jackson et al., 
1980; Paulin et al., 1980), but all three clones were still able to form tumors 
and  form  bone  in  experimental  tumors,  accompanied  by  an  onset  of 
vimentin expression. The findings that genetic programs apparently can be 
turned on/off in a controlled way and that multiple clones performed in the 
same way favor plasticity as the underlying force. 
 
Collagen type I and II expression showed an unexpected expression pattern 
in the experimental osteosarcoma tumors where collagen type II, normally 
found in cartilage, was expressed in the highly differentiated foci of bone in 
the  experimental  osteosarcomas.  On  the  other  hand,  collagen  type  I, 
normally  expressed  in  bone  tissues,  was  not  expressed  in  the  highly 
differentiated foci of bone in the same tumors. Both collagen type I and II 
were  expressed  in  the  experimental  osteosarcomas  in  the  areas  of   31 
undifferentiated and less differentiated bone tissue surrounding the foci of 
bone.  It  has  been  reported  that  during  chondroid  differentiation 
coexpression of collagen I and II can occur and that the expression profile 
change during the course of differentiation (Hegert et al., 2002; Poliard et 
al., 1999). 
 
The  third  primary  tumor,  the  carcinoma,  gave  rise  to  clones  where  the 
majority (4/5) lost the expression of keratin, an epithelial marker, in vitro. 
The experimental tumors from the carcinoma also showed low expression 
of keratins and some tumors lacked keratin expression. The morphology 
was  spindle-cell  (fibroblast)  like,  i.e.,  showed  no  sign  of  epithelial 
morphology  as  the  primary  tumor.  The  conclusion  was  that  carcinoma 
clones formed tumors in line with an EMT.  
 
Another  possible  explanation  for  our  results  was  clonal  heterogeneity  or 
clonal evolution (Campbell and Polyak, 2007). According to such a model, 
the  acquirement  of  mutations  during  cell  culture  could  generate 
heterogeneity in our experimental tumors. However clonal evolution was 
not considered to be the cause of the heterogeneity in our experimental 
setup for the following reasons: Considerable effort was put on minimizing 
the influence of clonal evolution by using the cell clones at a low passage 
number.  Further,  bone  formation  is  the  result  of  complicated  genetic 
programs  and  not  likely  to  be  the  result  of  mutations  by  chance.  Bone 
formation  was  seen  in  a  number  of  tumors  from  5  different  clones  (3 
osteosarcoma clones and 2 spindle-cell clones) and that seems more than a 
coincidence and likely the result of plastic tumor stem cells. 
 
 
BMP expression and tumor phenotype (Paper II and III) 
 
The mRNA expression profile of a number of different BMPs was studied 
in the cell clones from the same three primary tumors as above. In addition, 
Smad  activation  and  expression  of  BMP-6  protein  were  studied  in  the 
experimental  tumors.  A  high  expression  of  several  BMPs  was  found  not 
only in the osteosarcoma clones but, unexpectedly, also in the spindle-cell 
clones. The primary spindle-cell tumor displayed no bone formation and 
hence it was expected that the clones derived from the tumor would express 
low levels of BMPs. However expression of BMP-2,-3B,-4,-5,-6,-7 and -8 
was found in the ostesarcoma- and spindle-cell clones, but the expression   32 
patterns in the different clones varied significantly. Further, the carcinoma 
clones showed low but clearly detectable expression of BMP-2 and -4.  
 
As  in  the  first  study  it  was  important  to  work  with  low  passages  of  the 
clones to ensure that the expression patterns found represented that of the 
primary  tumor.  There  is  increasing  information  on  BMPs  in  relation  to 
tumor growth and invasion and in most cases BMPs are expressed without 
causing bone formation (Alarmo et al., 2007; Helms et al., 2005). In breast 
cancer research, BMPs are studied and associated with metastasis to bone, 
which  is  relatively  common  in  human  breast  cancer  (Misdorp  and  den 
Herder, 1966; Pratap et al., 2006). In canine mammary tumors, on the other 
hand,  metastasis  to  bone  is  uncommon  (Hellmen  and  Svensson,  1995; 
Misdorp et al., 1999). BMPs were also expressed in the carcinoma clones 
(Paper  II)  but  at  much  lower  levels.  In  development,  BMPs  have 
pleiotrophic roles and are essential in, for example, neural crest specification 
(Trainor et al., 2003; Tribulo et al., 2003) and dorsal differentiation of neural 
plate cells (Liem et al., 1995). It is possible that BMPs are active in a number 
of tumors but only in a minority does the expression result in osteosarcoma 
formation. In our experimental setup it was also shown that some clones 
with high expression of BMPs were unable to form tumors in the mice 
(CMT-U309,  clone  1  and  2).  The  conclusion  drawn  was  that  BMP 
expression was not correlated to tumorigenecity. 
 
In an attempt to correlate the BMP expression patterns of the clones in vitro 
and the phenotype of the formed experimental tumors, the results suggested 
that BMP-6 was needed for bone formation. The clearest example was the 
osteosarcoma  clone  6  that  had  very  high  expression  of  BMP-4  but  no 
expression  of  BMP-6  and  formed  spindle-cell  tumors  in  contrast  to  the 
other  osteosarcoma  clones.  BMP-6  has  in  several  studies  been  linked  to 
bone formation in both development and in tumors (Akiyoshi et al., 2004; 
Jane et al., 2002; Kang et al., 2004; Kugimiya et al., 2005; Sammons et al., 
2004).  Further,  activated  (phosphorylated)  Smad  1/5  was  studied  to  see 
whether the BMP pathway was activated in the experimental tumors, in an 
attempt to evaluate the relevance of expressed BMPs in the clones. The 
analysis of Smad 1/5 activation supported the importance of BMP-6 since 
the  Smad  1/5  pathway  was  active  in  experimental  tumors  derived  from 
BMP-6  mRNA  expressing  clones.  It  was  also  shown  that  clones  could 
respond to BMP stimulation and result in Smad 1/5 phosphorylation; in 
other  words  the  clones  should  be  capable  of  autocrine  stimulation.  The 
presence of BMP-6 protein was verified in the experimental tumors that   33 
formed bone. It was thereby shown that the amount of protein expressed 
corresponded to the level of mRNA expressed in the respective clone, i.e. 
the osteosarcoma clone with very low BMP-6 mRNA expression had low 
expression  of  BMP-6  protein.  Surprisingly,  the  experimental  carcinoma 
tumors expressed BMP-6 protein. On the other hand, the tumors showed 
very little Smad 1/5 activity and therefore most likely, low levels of BMP 
signal had transduced to the nucleus and target genes. 
 
BMPs were also shown to be upregulated in the ostosarcomas (Paper III). 
BMP-2, -4, -5, and -6 showed all high expression in osteosarcomas. This 
supports the importance of BMPs for the osteosarcoma phenotype. Further, 
BMP-2 was also expressed in two fibrosarcomas and in the carcinoma that 
was of basal cell type. That observation supports the RPA analysis where 
BMP-2  was  expressed  by  carcinoma  and  spindle-cell  clones.  BMPs  are 
among the known inducers of EMT (Kiefer et al., 2008) and therefore can 
be thought to influence the ability of a tumor to metastasize.  
 
 
 Craniofacial and neural crest signature (Paper I and III) 
 
The third study in this thesis is a gene expression study where the global 
gene expression was investigated in a number of primary mammary tumors; 
osteosarcomas  (n=5),  fibrosarcomas  (n=6),  simple  carcinomas  (n=7)  and 
normal  mammary  tissues  were  used  as  controls  (n=4).  Affymetrix 
GeneChip® expression arrays were used and the expression data showed 
signs of high quality and reliability for the following reasons: Firstly, the 
tumor  groups  clustered  well  together  when  the  data  were  subjected  to 
unsupervised  clustering.  Secondly,  the  sarcomas  clustered  together  and 
carcinomas clustered next to the normal mammary tissue controls with the 
expression of epithelial genes as common feature. Further, the tumor groups 
were compared by supervised clustering and a high number of tissue-specific 
genes were expressed in the respective group, i.e. bone related genes in the 
osteosarcomas,  other  mesenchymal  and  cell-matrix  adhesion  genes  in  the 
fibrosarcomas and epithelial genes in the carcinomas. It could therefore be 
stated that the data revealed a good correlation between gene expression 
profile and histological classification.  
 
It was observed that several homeobox transcription factors were among the 
most  differentially  expressed  genes  when  comparing  the  tumor  groups 
(carcinomas vs sarcomas) and this called for a closer look into the expression   34 
of  homeobox  genes,  an  important  group  of  developmental  genes  that 
includes several mastergenes. A supervised clustering of all the homeobox 
genes  present  on  the  array  revealed  that  the  sarcomas,  especially  the 
osteosarcomas,  expressed  many  homeobox  transcription  factors.  To  our 
surprise, two carcinomas (203B and P208) expressed homeobox genes and 
thereby  clustered  among  the  sarcomas.  However,  these  two  carcinomas 
turned  out  to  be  special,  in  that  they  were  shown  to  be  a  lipid-rich 
carcinoma and a basal cell carcinoma, respectively.  
 
Interestingly,  a  great  number  of  the  homeobox  genes  identified  in  this 
study, for example Goosecoid (Yamada et al., 1995), SatB2 (Dobreva et al., 
2006), MSX1 and MSX2 (Hosokawa et al., 2007; Ishii et al., 2005), DLX5 
and DLX6 (Robledo et al., 2002), paired related homeobox 1 (Lu et al., 
1999)  and  SIP1/ZEB2  (Van  de  Putte  et  al.,  2003)  have  previously  been 
linked  to  craniofacial  bone  development;  in  total  16  homeobox  genes 
expressed  in  the  sarcomas  have  been  found  to  be  active  in  craniofacial 
development (Table 1) and craniofacial bones are dependent on neural crest 
to develop.  
 
Table 1. Homeobox genes expressed in sarcomas (published as supplementary material to Paper III). 
The order of appearance is the same as in Fig 2 in Paper III 
Gene name  Role in craniofacial development 
DLX-5  Msx1 and Dlx5 act independently in development of 
craniofacial skeleton, but converge on the regulation of 
Bmp signaling in palate formation.(Levi et al., 2006)  
The Dlx5 and Dlx6 homeobox genes are essential for 
craniofacial, axial, and appendicular skeletal development 
(Robledo et al., 2002) 
Paired-like homeodomain 
transcription factor 2 (PITX2) 
isoform c 
Genetic dissection of Pitx2 in craniofacial development 
uncovers new functions in branchial arch 
morphogenesis, late aspects of tooth morphogenesis and 
cell migration. (Liu et al., 2003) 
Paired related homeobox 1  prx-1 functions cooperatively with another paired-
related homeobox gene, prx-2, to maintain cell fates 
within the craniofacial mesenchyme. (Lu et al., 1999) 
SIP1/ZEB2   Mice lacking ZFHX1B, the gene that codes for Smad-
interacting protein-1, reveal a role for multiple neural 
crest cell defects in the etiology of Hirschsprung disease-
mental retardation syndrome. (Van de Putte et al., 2003)   35 
 
MSX2  TGF-beta mediated Msx2 expression controls occipital 
somites-derived caudal region of skull development. 
(Hosokawa et al., 2007) 
Combined deficiencies of Msx1 and Msx2 cause 
impaired patterning and survival of the cranial neural 
crest. (Ishii et al., 2005) 
Homeobox DLX-6  The Dlx5 and Dlx6 homeobox genes are essential for 
craniofacial, axial, and appendicular skeletal development 
(Robledo et al., 2002) 
Homeobox BarH-like 1   Cloning, characterization, localization, and mutational 
screening of the human BARX1 gene. (Gould and 
Walter, 2000) 
MSX1  Combined deficiencies of Msx1 and Msx2 cause 
impaired patterning and survival of the cranial neural 
crest. (Ishii et al., 2005)  
Msx1 and Dlx5 act independently in development of 
craniofacial skeleton, but converge on the regulation of 
Bmp signaling in palate formation. (Levi et al., 2006) 
Homeobox A2  Temporal requirement of Hoxa2 in cranial neural crest 
skeletal morphogenesis. (Santagati et al., 2005) 
SatB2  Satb2 haploinsufficiency phenocopies 2q32-q33 
deletions, whereas loss suggests a fundamental role in the 
coordination of jaw development. (Britanova et al., 
2006)   
SATB2 is a multifunctional determinant of craniofacial 
patterning and osteoblast differentiation. (Dobreva et al., 
2006) 
Paired mesoderm homeobox 
protein 2 (PRX-2) 
prx-1 functions cooperatively with another paired-
related homeobox gene, prx-2, to maintain cell fates 
within the craniofacial mesenchyme. (Lu et al., 1999) 
Goosecoid  Targeted mutation of the murine goosecoid gene results 
in craniofacial defects and neonatal death. (Yamada et al., 
1995) 
LIM homeobox proten 1  Requirement for Lim1 in head-organizer function. 
(Shawlot and Behringer, 1995) 
SIX1 (Sine oculis homeobox 
homolog 1) 
Thymus, kidney and craniofacial abnormalities in Six 1 
deficient mice. (Laclef et al., 2003) 
pituitary homeobox 1 
(PITX1)(hindlimb expressed 
homeobox protein backfoot) 
Deletion of the Pitx1 genomic locus affects mandibular 
tooth morphogenesis and expression of the Barx1 and 
Tbx1 genes. (Mitsiadis and Drouin, 2008) 
Homeobox A7  Craniofacial abnormalities induced by ectopic expression 
of the homeobox gene Hox-1.1 in transgenic mice. 
(Balling et al., 1989) 
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Another group of genes related to bone formation, the BMP genes, were 
found to be expressed mainly in the sarcomas. Further, in a search for genes 
known to interact with homeobox genes, genes involved in retinoic acid 
signaling were identified.  
 
Homeobox genes together with BMPs and genes related to retinoic acid 
signaling have important roles in early embryonic development and neural 
crest formation and specification (Ko et al., 2007; Steventon et al., 2009), 
including  craniofacial  development.  Neural  crest  give  rise  to  as  diverse 
tissues  as  peripheral  nerves,  smooth  muscle,  cartilage,  bone  and  teeth 
(Trainor et al., 2003). With those kinds of genetic programs activated, it can 
not  only  explain  the  ability  of  tumor  cells  to  form  bone  but  also  the 
expression  of  other  genes  like  neural  genes  e.g.,  Microtubule  associated 
protein 1A and transcription factor COE1 involved in dendritic branching 
and development of medium spiny neurons, respectively and glial genes like 
meteorin.  Moreover,  tooth  markers  like  dentin,  sialophosphoprotein  and 
amelogenin are expressed. In fact, the expression of neurofilament (Paper I) 
can be explained by neural crest genetic programs. It is genetic programs 
like these that are the key to the diversity seen in mammary sarcomas. 
 
 
Differences between carcinomas and sarcomas (Paper I-III) 
  
Homeobox genes (Paper III) have roles early in development and can be 
considered  as  progenitor  or  stem  cell  markers,  for  example,  Goosecoid 
(Boucher et al., 2000), DLX-5 (Tonchev et al., 2006) and Homeobox B4 
(Chan et al., 2008). BMPs (Paper II and III) are also important for stem cell 
signaling. It is stem- and progenitor cells that are the main targets of BMPs 
(Wagner, 2007). Sarcomas expressed a higher number of homeobox and 
BMP genes than did the carcinomas, indicating that sarcomas probably have 
a larger fraction of tumor stem cells than carcinomas. The results presented 
in this thesis (Paper I and III) indicate that sarcomas are more plastic and 
show more diversity in RNA and protein expression than carcinomas.  
 
Recent studies reveal that only a few mutations can transform a fibroblast to 
a cell with stem cell properties (Takahashi et al., 2007; Yu et al., 2007) and 
that fact also influences the way to think about tumorigenesis and tumor 
stem cells. There are probably several types of cells in the mammary gland 
that  can  be  transformed  to  a  tumor  stem  cell.    In  the  future,  the   37 
identification of genetic programs that are related to biological properties 
will be important. For example, the two carcinomas that were lipid rich 
carcinoma and basal cell carcinoma (Paper III) could be distinguished from 
the other carcinomas due to their homeobox expression that most probably 
determine properties of those two tumors.    38   39 
Conclusions 
The results in this thesis indicate that mammary sarcomas are plastic. They 
appear to have the ability to turn on and off genetic programs and express 
genes associated with progenitor/stem cells. Carcinomas also showed ability 
to transform, in line with an EMT, but did not have the same diversity in 
gene expression as the sarcomas. 
 
The specific conclusions: 
 
↟ Osteosarcoma clones can turn off and on the bone forming program, a 
sign of plasticity. Spindle-cell clones also formed bone and carcinoma clones 
performed an EMT. 
 
↟ Osteosarcoma and spindle-cell clones expressed many different BMPs and 
BMP-6 which could be important for bone formation. 
 
↟  Expression  of  many  homeobox  genes  crucial  in  development  were 
identified in sarcomas. The homeobox gene expression pattern can explain 
the  heterogenous  expression  among  sarcomas  of,  for  example,  bone, 
cartilage, nerve, glial and tooth markers. 
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Future perspectives 
More knowledge tends to generate even more questions and that is the case 
with this thesis. There are several lines of research that could be pursued. To 
start with it would be interesting to design experiments and study how the 
homeobox genes identified in Paper III influences metastasis and survival 
rates. There is an increasing number of studies in which homebox genes 
have been identified as drivers of metastasis. Interestingly, the majority of 
those  homeobox  genes  were  also  expressed  in  sarcomas  (Paper  III),  but 
many of the homeobox genes expressed in the sarcomas have never been 
studied in tumors or in relation to metastasis. Hand in hand with this comes 
also the identification of prognostic markers that could be useful in the clinic 
to predict survival. Increased knowledge of the actors in metastasis are the 
basis for the development of new treatment of highly malignant tumors or 
even preventing tumors from establishing distant metastasis.  
 
It would also be interesting to further investigate the differences between 
sarcomas and carcinomas. Perhaps it is easier to identify metastasis genes in 
primary sarcomas than in carcinomas due to the small number of stromal 
cells  in  sarcomas,  an  advantage  when  preparing  RNA  from  tumor 
specimens. In addition sarcoma cells do not have to perform an EMT before 
metastasizing. There are probably lessons to be learned from sarcomas but, 
first, the relevance for carcinoma metastasis has to be evaluated. Are the two 
tumor groups dependent on the same genetic programs to metastasize or is 
there more than one metastasis program? 
 
There are studies that link BMP to EMT and tumor metastasis but there are 
not many target genes or modulators of BMP signaling identified in that 
process.  There  is  one  example  of  homeobox  connection  with  TGF-β 
signalling: the homeobox SIP1/ZEB2 regulate Smad signaling (Postigo et   42 
al.,  2003).  One  approach  to  test  if  BMP  signaling  is  dependent  on 
homeobox proteins would be to perform proximity ligation assays (PLA) 
between phosphorylated Smad 1/5 and different homeobox genes expressed 
in Paper III. During the preparation of Paper III an attempt was made to 
perform such an analysis but due to unspecific antibodies the results were 
not included.  
 
Another aspect of the neural crest signature (Paper III) is that neural crest in 
relation  to  mammary  development  is  very  little  studied.  The  probable 
reason  is  that  developmental  studies  most  often  are  based  on  non-
mammalian  models.  The  question  is  if  neural  crest  cells  are  involved  in 
mammary  gland  development  in  the  way  they  are  in  tooth (Jiang  et  al., 
2008) or hair follicle (Sieber-Blum et al., 2004) development. Teeth, hair 
follicles and mammary glands are all formed from epidermal appendages in a 
similar way and, for example, mutation of the genes MSX1/2 and Lef-1 will 
affect  the  development  of  all  epidermal  appendages  including  mammary 
glands (Hennighausen and Robinson, 2001). It is not unlikely that neural 
crest cells are involved in mammary gland development and contribute to 
the progenitor pool in the mammary. Filling in these gaps of knowledge 
concerning  mammary  gland  development  would  be  clearly  beneficial  for 
mammary tumor research.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   43 
Populärvetenskaplig sammanfattning 
 
Brösttumörer  är  den  vanligaste  typen  av  tumörer  både  hos  kvinnor  och 
tikar, och hos hund kallas dessa juvertumörer. Det finns en stor mängd olika 
typer av tumörer som kan uppstå i juvret och denna mångfald har förbryllat 
forskare i många decennier. De flesta juvertumörer är karcinom, det vill säga 
de  har  en  epitelstruktur  liknande  den  som  juvrets  körtlar  består  av. 
Dessutom  finns  sarkom  som  består  av  stödvävnadslika  celler,  t.ex.  ben-, 
brosk-,  bindväv-,  och  muskeltumörer.  Särskilt  hur  brosk  och  ben  i 
juvertumörer uppstår har varit ett frågetecken.  
 
På senare år har det framkommit att tumörer till viss del består av celler med 
stamcellsegenskaper, så kallade tumörstamceller. En egenskap som förenar en 
vanlig stamcell med en tumörstamcell är bland annat möjligheten att bilda 
dotterceller med helt andra egenskaper och med helt andra gener aktiva. 
Denna förändring av egenskaper kännetecknar plasticitet. Tumörstamceller 
skulle kunna vara orsaken till den mångfald som ses bland juvertumörer. 
 
Syftet  med  denna  avhandling  har  varit  att  få  kunskap  om  tumörcellers 
plasticitet d.v.s. förmåga att sätta på/stänga av gener. Vidare har målet varit 
att försöka identifiera aktiva gener, normalt viktiga i embryonalutvecklingen, 
hos olika typer av tumörer. Särskilt karcinom och sarkom har jämförts.  
 
I den första studien studerades tre tumörer, två sarkom (en bentumör och en 
bindvävstumör) och ett karcinom. Enskilda celler separerades ut och tilläts 
ge upphov till kloner. Dessa kloner studerades först i cellodling och sedan 
efter  att  de  återigen  bildat  experimentella  juvertumörer  från  hund  under 
skinnet på möss. Cellmarkörer studerades, vars förekomst avslöjar celltypen, 
d.v.s. om det är en ben-, brosk-, muskel-, epitel- eller nervcell. Det visade   44 
sig  att  när  man  följde  förekomsten  av  markörer  i  modertumören,  i 
cellklonerna  och  i  de  experimentella  tumörerna  så  hade  tumörcellerna 
förmåga  att  ändra  förekomsten  av  markörer.  Särskilt  bentumörens  celler 
visade  egenskaper  som  var  stamcellslika.  Sarkomen  var  mer  plastiska  och 
visade mer mångfald än karcinomet. 
 
Det står mer och mer klart att gener och fenomen som är viktiga i tidig 
embryonalutveckling  även  har  en  mycket  framträdande  roll  i 
tumörutveckling. Den andra och tredje studien inriktades därför på gener 
som är viktiga i embryonalutveckling. Två viktiga genfamiljer studerades; 
bone  morphogenetic  proteins  (fritt  översatt;  benutvecklingsproteiner), 
viktiga för såväl tidig embryonalutveckling, utveckling av bröst/juver och 
benbildning. En annan grupp av gener som studerades var homeobox-gener, 
en  av  de  allra  viktigaste  gengrupperna  i  utvecklingen  av  embryot. 
Homeobox-gener  utför  planritningen  och  bestämmer  placering  av 
extremiteter och bildandet av flertalet organ varav bröst/juver är ett av dem. 
Två  grupper  med  sarkom  studerades  (även  denna  gång  bentumörer  och 
bindvävstumörer)  och  de  jämfördes  mot  en  grupp  karcinom.  Det  var 
sarkomen som hade flest av dessa embryonalutvecklingsgener aktiva, gener 
som normalt har sin verkan i och på stamceller i embryot. Dessa resultat kan 
tyda på att sarkom har fler tumörstamceller än karcinom.  
 
Att  sarkomen  och  särskilt  bentumörerna  hade  många  homeobox-gener 
aktiva var ett mycket intressant fynd. Med tanke på vad som redan är känt 
om homeobox-genernas funktion, blir slutsatsen att benet i bentumörerna 
bildas på samma sätt som ansiktets ben. En i sin tur viktig komponent i 
bildandet  av  ansiktets  ben  är  neurallistceller.  I  embryoutvecklingen  ger 
neurallistceller  upphov  till  ett  mycket  varierat  utbud  av  vävnad  såsom 
nerver, tänder och pigmentceller. Mycket intressant var att neurallistgener 
också var aktiva i sarkomen som studerats, till exempel fanns aktiva gener 
som normalt finns i nerv och tand. Dessa fynd ger inblick i hur mångfalden 
bland juvertumörer framförallt sarkom uppstår.  
 
I denna avhandling har flera homeobox-gener identifierats som förut inte 
studerats i tumörer. Tidigare har andra homeobox-gener förknippats med 
tumörspridning (metastasering). Framtida studier av homebox-gener kan ge 
mer förståelse för hur tumörer sprider sig, vilket behövs för att få fram nya 
behandlingar av elakartade tumörer. 
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